Suboptimal use of HIV drug resistance testing in a universal health-care setting

References

• Alexander , C.S. , Dong , W. , Schechter , M.T. , O'Shaughnessy , M.V. , Strathdee , S.A. , Mo , T. and Harrigan , P.R. 1999 . Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users . AIDS , 13 ( 8 ) : 981 – 985 .
   PubMed Web of Science ®Google Scholar
• Alexander , C.S. , Dong , W. , Chan , K. , Jahnke , N. , O'Shaughnessy , M.V. , Mo , T. and Harrigan , P.R. 2001 . HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort . AIDS , 15 ( 5 ) : 601 – 607 .
   PubMed Web of Science ®Google Scholar
• Bangsberg , D.R. , Perry , S. , Charlebois , E.D. , Clark , R.A. , Roberston , M. , Zolopa , A.R. and Moss , A. 2001 . Non-adherence to highly active antiretroviral therapy predicts progression to AIDS . AIDS , 15 ( 9 ) : 1181 – 1183 .
   PubMed Web of Science ®Google Scholar
• Baxter , J.D. , Mayers , D.L. , Wentworth , D.N. , Neaton , J.D. , Hoover , M.L. , Winters , M.A. and Merigan , T.C. 2000 . A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS . AIDS , 14 ( 9 ) : F83 – 93 .
   PubMed Web of Science ®Google Scholar
• British Columbia Centre for Excellence in HIV/AIDS 2009 Therapeutic guidelines: Antiretroviral treatment of adult HIV infection (February 2009) Retrieved September 4, 2009, from http://www.cfenet.ubc.ca/content.php?id=118
   Google Scholar
• Buchacz K. Baker R.K. Young B. Brooks J.T. the HIV Outpatient Study (HOPS) Investigators 2010 . Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006 Journal of Acquired Immune Deficiency Syndrome 53 5 625 632
   PubMed Web of Science ®Google Scholar
• Carpenter , C.C. , Fischl , M.A. , Hammer , S.M. , Hirsch , M.S. , Jacobsen , D.M. , Katzenstein , D.A. and Volberding , P.A. 1997 . Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel . JAMA , 277 ( 24 ) : 1962 – 1969 .
   PubMed Web of Science ®Google Scholar
• Chan , C.W. , Cheng , L.S. , Chan , W.K. and Wong , K.H. 2005 . Highly active antiretroviral therapy per se decreased mortality and morbidity of advanced human immunodeficiency virus disease in Hong Kong . Chinese Medical Journal (English) , 118 ( 16 ) : 1338 – 1345 .
   PubMed Web of Science ®Google Scholar
• Durant , J. , Clevenbergh , P. , Halfon , P. , Delgiudice , P. , Porsin , S. Simonet , P. 1999 . Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial . Lancet , 353 ( 9171 ) : 2195 – 2199 .
   PubMed Web of Science ®Google Scholar
• Dybul , M. , Fauci , A.S. , Bartlett , J.G. , Kaplan , J.E. and Pau , A.K. 2002 . Guidelines for using antiretroviral agents among HIV-infected adults and adolescents . Annals of Internal Medicine , 137 ( 5 Pt 2 ) : 381 – 433 .
   PubMed Web of Science ®Google Scholar
• Hammer , S.M. , Eron , J.J. Jr , Reiss , P. , Schooley , R.T. , Thompson , M.A. , Walmsley , S. and Volberding , P.A. 2008 . Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel . JAMA , 300 ( 5 ) : 555 – 570 .
   PubMed Web of Science ®Google Scholar
• Harrigan , P.R. , Hogg , R.S. , Dong , W.W. , Yip , B. , Wynhoven , B. , Woodward , J. and Montaner , J.S. 2005 . Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy . The Journal of Infectious Diseases , 191 ( 3 ) : 339 – 347 .
   PubMed Web of Science ®Google Scholar
• Hirsch , M.S. , Conway , B. , D'Aquila , R.T. , Johnson , V.A. , Brun-Vezinet , F. , Clotet , B. and Richman , D.D. 1998 . Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management. International AIDS Society–USA Panel . JAMA , 279 ( 24 ) : 1984 – 1991 .
   PubMed Web of Science ®Google Scholar
• Hirsch , M.S. , Günthard , H.F. , Schapiro , J.M. , Brun-Vézinet , F. , Clotet , B. , Hammer , S.M. and Richman , DD. 2008 . Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel . Clinical Infectious Disease , 47 ( 2 ) : 266 – 285 .
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Heath , K.V. , Yip , B. , Craib , K.J. , O'Shaughnessy , M.V. , Schechter , M.T. and Montaner , J.S. 1998 . Improved survival among HIV-infected individuals following initiation of antiretroviral therapy . JAMA , 279 ( 6 ) : 450 – 454 .
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Bangsberg , D.R. , Lima , V.D. , Alexander , C. , Bonner , S. , Yip , B. and Harrigan , P.R. 2006 . Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART . PLoS Medicine , 3 ( 9 ) : 356
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Yip , B. , Chan , K.J. , Wood , E. , Craib , K.J. , O'Shaughnessy , M.V. and Montaner , J.S. 2001 . Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy . JAMA , 286 ( 20 ) : 2568 – 2577 .
   PubMed Web of Science ®Google Scholar
• Jerene D. Naess A. Lindtjørn B. 2006 . Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients AIDS Research and Therapy 3 10
   PubMedGoogle Scholar
• Johnson , V.A. , Brun-Vezinet , F. , Clotet , B. , Gunthard , H.F. , Kuritzkes , D.R. Pillay , D. 2008 . Update of the drug resistance mutations in HIV-1: Spring 2008 . Topics in HIV Medicine , 16 ( 1 ) : 62 – 68 .
   PubMedGoogle Scholar
• Kitahata , M.M. , Van Rompaey , S.E. and Shields , A.W. 2000 . Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy . Journal of Acquired Immune Deficiency Syndrome , 24 ( 2 ) : 106 – 114 .
   PubMed Web of Science ®Google Scholar
• Larder , B.A. , Kohli , A. , Kellam , P. , Kemp , S.D. , Kronick , M. and Henfrey , R.D. 1993 . Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing . Nature , 365 ( 6447 ) : 671 – 673 .
   PubMed Web of Science ®Google Scholar
• Lima , V.D. , Gill , V.S. , Yip , B. , Hogg , R.S. , Montaner , J.S.G. and Harrigan , P.R. 2008 . Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy . The Journal of Infectious Diseases , 198 ( 1 ) : 51 – 58 .
   PubMed Web of Science ®Google Scholar
• Lorenzi , P. , Opravil , M. , Hirschel , B. , Chave , J.P. , Furrer , H.J. , Sax , H. and Yerly , S. 1999 . Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study . AIDS , 13 ( 2 ) : F17 – 21 .
   PubMed Web of Science ®Google Scholar
• Maldonado , G. and Greenland , S. 1993 . Simulation study of confounder-selection strategies . American Journal of Epidemiology , 138 ( 11 ) : 923 – 936 .
   PubMed Web of Science ®Google Scholar
• Masuhr , A. , Mueller , M. , Simon , V. , Zwingers , T. , Kurowski , M. , Jessen , H. and Arastéh , K. 2002 . Predictors of treatment failure during highly active antiretroviral therapy (racing trial) . European Journal of Medical Research , 7 ( 8 ) : 341 – 346 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A. , Gill , M.J. , Davidson , W. and Phillips , A.N. 2000 . Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? . Journal of Acquired Immune Deficiency Syndrome , 24 ( 5 ) : 475 – 482 .
   PubMed Web of Science ®Google Scholar
• Murphy E.L. Collier A.C. Kalish L.A. Assmann S.F. Para M.F. Flanigan T.P. Viral Activation Transfusion Study Investigators 2001 . Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease Annals of Internal Medicine 135 1 17 26
   PubMed Web of Science ®Google Scholar
• Nokes , K.M. 1998 . Revisiting how the Chronic Illness Trajectory Framework can be applied for persons living with HIV/AIDS . Scholarly Inquiry for Nursing Practice , 12 ( 1 ) : 27 – 31 .
   PubMedGoogle Scholar
• Palella , F.J. Jr , Delaney , K.M. , Moorman , A.C. , Loveless , M.O. , Fuhrer , J. , Satten , G.A. and Holmberg , S.D. 1998 . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators . The New England Journal of Medicine , 338 ( 13 ) : 853 – 860 .
   PubMed Web of Science ®Google Scholar
• Paul S.M. Jorden V.S. 2003 . HIV resistance testing. A clinical tool New Jersey Medicine: The Journal of the Medical Society of New Jersey 100 9 Suppl 44 49
   PubMedGoogle Scholar
• Richman , D.D. , Havlir , D. , Corbeil , J. , Looney , D. , Ignacio , C. , Spector , S.A. and Pauletti , D. 1994 . Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy . Journal of Virology , 68 ( 3 ) : 1660 – 1666 .
   PubMed Web of Science ®Google Scholar
• Siegel , K. and Lekas , H.-M. 2002 . AIDS as a chronic illness: Psychosocial implications . AIDS , 16 ( Suppl. 4 ) : S69 – 76 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J.S.G. , Tyndall , M.W. , Schechter , M.T. , O'Shaughnessy , M.V. and Hogg , R.S. 2003 . Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy . The Journal of Infectious Diseases , 188 ( 8 ) : 1164 – 1170 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Hogg , R.S. , Yip , B. , Harrigan , P.R. , O'Shaughnessy , M.V. and Montaner , J.S. 2003 . Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L . Annals of Internal Medicine , 139 ( 10 ) : 810 – 816 .
   PubMed Web of Science ®Google Scholar
• Yeni , P.G. , Hammer , S.M. , Hirsch , M.S. , Saag , M.S. , Schechter , M. , Carpenter , C.C.J. and Volberding , P.A. 2004 . Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel . JAMA , 292 ( 2 ) : 251 – 265 .
   PubMed Web of Science ®Google Scholar